Screener
Xenon Pharmaceuticals XENE Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $5.83B.
The source filing: Xenon Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338244
FAQ
- What is Xenon Pharmaceuticals's market capitalization?
- Xenon Pharmaceuticals (XENE) reported market capitalization of $5.83B in Q2 2026.
- How has Xenon Pharmaceuticals's market capitalization changed year-over-year?
- Xenon Pharmaceuticals's market capitalization increased by 136.4% year-over-year, from $2.47B to $5.83B.
- What is the long-term trend for Xenon Pharmaceuticals's market capitalization?
- Over 5 years (2020 to 2025), Xenon Pharmaceuticals's market capitalization has grown at a 34.3% compound annual growth rate (CAGR), from $793.44M to $3.46B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Xenon Pharmaceuticals's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude